This act establishes non-mandatory guidance for private employers and mandatory requirements for federal agencies regarding opioid overdose reversal medication in the workplace.
Jeff Merkley
Senator
OR
The WORK to Save Lives Act aims to combat workplace opioid overdoses by providing non-mandatory guidance to private employers on stocking and training for overdose reversal medication. Additionally, the bill mandates that all federal agencies must acquire and maintain this medication and provide annual employee training on its use. This legislation seeks to ensure preparedness for opioid emergencies across various workplaces.
The WORK to Save Lives Act is a direct response to the opioid crisis, focusing on the places where many of us spend most of our waking hours: the workplace. The bill takes a two-pronged approach to overdose prevention. First, it makes it mandatory for every federal agency to stock opioid overdose reversal medications (like Naloxone) and ensure their staff knows how to use them through annual training. Second, it tasks the Department of Labor with creating a playbook for private businesses to do the same, though for non-government bosses, following these steps remains optional. By placing these life-saving tools in office buildings and job sites, the bill aims to turn the workplace into a frontline defense against accidental overdose deaths.
Under Section 3, the government is leading by example. Within 270 days of the bill becoming law, every federal agency—including the Veterans Health Administration—must acquire and maintain a supply of overdose reversal medication. This isn't just about having a kit gathering dust in a closet; the law requires annual training for employees. For a worker at a Social Security office or a technician at a VA hospital, this means their workplace safety protocols will now include the same kind of 'stop the bleed' or CPR preparedness we see for other medical emergencies. The bill specifically overrides certain existing restrictions for the VA to ensure they are fully included in these requirements.
For those of us working in the private sector, Section 2 of the bill focuses on guidance rather than red tape. The Secretary of Labor, via OSHA, has the same 270-day window to issue non-mandatory guidance for employers. This guidance will act as a 'how-to' manual for businesses—from local retail shops to major construction firms—on how to buy the medication and how to train their teams effectively. While a private manager won't face federal penalties for opting out, the goal is to lower the barrier to entry by providing clear, professional standards for any business owner who wants to add overdose reversal to their first-aid toolkit.
In practice, this bill treats an opioid overdose like a fire or a heart attack—a workplace hazard that can be managed with the right equipment and a little bit of knowledge. If you are a federal employee, your job site will soon be equipped to handle an emergency that might otherwise be fatal before an ambulance arrives. For everyone else, the bill creates a standardized framework that takes the guesswork out of workplace safety. By defining 'employer' broadly but excluding the U.S. Postal Service from the non-mandatory guidance section, the bill sets a clear expectation: whether you’re in a government cubicle or a private warehouse, the tools to save a life should be within reach.